Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹5 Cr
Revenue (TTM)
₹2 Cr
Net Profit (TTM)
₹0 Cr
ROE
0.6 %
ROCE
0.8 %
P/E Ratio
--
P/B Ratio
0.1
Industry P/E
111.3
EV/EBITDA
-21
Div. Yield
0 %
Debt to Equity
0
Book Value
₹10.2
EPS
₹-0.1
Face value
10
Shares outstanding
31,287,330
CFO
₹-16.71 Cr
EBITDA
₹-5.53 Cr
Net Profit
₹1.07 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Symbiox Investment
| -17.1 | -19.4 | -12.8 | -52.8 | -24.3 | 10.6 | -- |
|
BSE Finance
| -13.8 | -13.6 | -14.5 | -0.8 | 10.2 | 8.6 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Symbiox Investment
| -65.6 | 79.5 | -44.2 | 144.2 | 158.5 | 208.4 | -51.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Finance
| 15.7 | 8.7 | 17.1 | 11.1 | 14.1 | 0.8 | 18.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Symbiox Investment
|
1.5 | 4.7 | 2.0 | -0.2 | -10.9 | -0.5 | -- | 0.1 |
| 13.8 | 70.7 | 33,655.8 | 4.8 | 0.0 | 14.3 | 14.8 | 1.9 | |
| 108.5 | 56.5 | 5.5 | 0.5 | 10.1 | 7.1 | 127 | 8.6 | |
| 90,883.2 | 1,817.7 | 180.2 | 130.2 | 95.5 | -- | 14 | 0.2 | |
| 387.3 | 305.9 | 139.4 | 2.0 | 2.9 | 7.3 | 192.4 | 6.0 | |
| 59.0 | 178.4 | 4.1 | 0.1 | 39.5 | 1 | 1621.6 | 4.4 | |
| 31.6 | 140.4 | 24.5 | 7.1 | 39.1 | 7.5 | 19.9 | 1.4 | |
| 5,089.0 | 2,604.9 | 86.1 | 23.0 | 40.6 | 0.1 | 111.3 | 0.2 | |
| 536.8 | 1,166.1 | 39.8 | 8.0 | 27.1 | 31.5 | 159.4 | 45.5 | |
| 752.0 | 524.3 | 99.1 | 13.8 | 23.3 | 25 | 38 | 8.1 |
No Review & Analysis are available.
Symbiox Investment & Trading Co Ltd trades in sarees in India. It offers sarees with embroidery work of stones, beads, etc., including plain, designer, cotton, and silk sarees. The company is also involved in financing activities. Symbiox Investment... & Trading Co Ltd was incorporated in 1979 and is based in Kolkata, India. Read more
Incorporated
1979
Chairman
--
Managing Director
Samit Ray
Headquarters
Kolkata, West Bengal
Website
Annual Reports
The share price of Symbiox Investment & Trading Co Ltd is ₹1.50 (BSE) as of 02-Apr-2026 IST. Symbiox Investment & Trading Co Ltd has given a return of -24.32% in the last 3 years.
Since, TTM earnings of Symbiox Investment & Trading Co Ltd is negative, P/E ratio is not available.
The P/B ratio of Symbiox Investment & Trading Co Ltd is 0.15 times as on 02-Apr-2026, a 96 discount to its peers’ median range of 3.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
52.04
|
0.31
|
|
2024
|
40.99
|
0.27
|
|
2023
|
67.98
|
0.35
|
|
2022
|
110.36
|
0.49
|
|
2021
|
40.99
|
0.09
|
The 52-week high and low of Symbiox Investment & Trading Co Ltd are Rs 3.77 and Rs 1.46 as of 04-Apr-2026.
Symbiox Investment & Trading Co Ltd has a market capitalisation of ₹ 5 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Symbiox Investment & Trading Co Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.